One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Report Library
  • Who Trust Us
  • Datafeature
  • [email protected]
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Report Library
  • Who Trust Us
  • Datafeature
Home ➤ Life Science ➤ Pharmaceuticals ➤ Heparin Market
Heparin Market
Heparin Market
Published date: March 2023 • Formats:
Request Sample
  • Home ➤ Life Science ➤ Pharmaceuticals ➤ Heparin Market

Global Heparin Market By Product (Weight Heparin, Unfractionated Heparin, Ultra-Low Molecular, and Low Molecular Weight Heparin), Application (Coronary Artery Disease, Atrial Fibrillation, Venous Thromboembolism, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Drug Stores & Retail Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

  • Published date: March 2023
  • Report ID: 15768
  • Number of Pages: 377
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • Quick Navigation

    • Report Overview
    • Market Scope
    • Key Market Segments
    • Drivers
    • Restraints
    • Trends
    • COVID-19 Impact Analysis
    • Regional Analysis
    • Key Players Analysis
    • Recent Development
    • Market Key Players
    • Report Scope

    Report Overview

    The global heparin market size is expected to be worth around USD 13.0 Billion by 2032 from USD 8.3 Billion in 2022, growing at a CAGR of 4.70% during the forecast period from 2022 to 2032.

    Heparin, commonly referred to as Unfractionated Heparin (UFH), is a naturally occurring glycosaminoglycan. In medicine, it serves as an anticoagulant (blood thinner). Treatment of unstable angina & heart attacks benefits greatly from it. This is injected directly into a vein or subcutaneously. Acute coronary syndrome, pulmonary embolism, deep-vein thrombosis, hemofiltration, atrial fibrillation, and cardiopulmonary bypass are just a few of the conditions it is utilized to treat. The execution of major orthopedic surgeries like knee and hip replacements also makes use of it.

    Global-Heparin-Market

    Market Scope

    Product Analysis

    The Low Molecular Weight Heparin Segment Accounted for the Largest Market Share in Product Type

    Based on product types, the global heparin market is segmented into weight heparin, unfractionated heparin, ultra-low molecular, and low molecular weight heparin.

    Among these products, the low molecular weight heparin occupied the largest market share and is anticipated to stay in the forecast period. Because heparin’s market expansion is influenced by several significant variables, including its prolonged & more predictable functioning than UFH, ease of self-administration at home through subcutaneous injection, which decreases hospital stays, and the lack of a daily blood checking requirement.

    Application Analysis

    The Coronary Artery Disease Segment Accounted for the Largest Market Share in Application Type

    Based on application types, the global heparin market is segmented into coronary artery disease, atrial fibrillation, venous thromboembolism, and others.

    Among these applications, the largest market share was occupied by coronary artery disease and is anticipated to stay in the forecast period. From 2023 to 2032, the global venous thromboembolism market is anticipated to experience rapid growth.

    Rising knowledge of thrombosis is one of the major factors propelling the segment’s growth. For instance, Haemostasias, Inc., and the Thrombosishas started an online site to educate patients about thrombosis.

    Global-Heparin-Market-by-application

    Distribution Channel Analysis

    The Hospital Pharmacies Segment Accounted for the Largest Market Share in Distribution Channel Type

    Based on distribution channel types, the global heparin market is segmented into online pharmacies, hospital pharmacies, and drug stores & retail pharmacies. Hospital pharmacies occupy the largest market share among these distribution channels and are anticipated to stay in the forecast period.

    Because the elevated services, easy availability of pharmaceuticals, and a growing dependence on medical practitioners for heparin recommendations all contribute to the growth of the hospital segment.

    Key Market Segments

    Product

    • Weight Heparin
    • Unfractionated Heparin
    • Ultra-Low Molecular
    • Low Molecular Weight Heparin

    Application

    • Coronary Artery Disease
    • Atrial Fibrillation
    • Venous Thromboembolism
    • Others

    Distribution Channel

    • Online Pharmacies
    • Hospital Pharmacies
    • Drug Stores & Retail Pharmacies

    Drivers

    Increased incidence of cardiovascular disorders is expected to drive the Market growth.

    The increased incidence of cardiovascular disorders, which will increase demand for these products, is a significant driving force affecting the global market. In the upcoming years, it is anticipated that nearly all types of cardiovascular disorders, including atrial fibrillation, strokes, venous thromboembolism, and heart-related problems, will continue to rise.

    These patterns and figures show that sizable patient populations are present worldwide, impacting the high demand for these goods. Additionally, the market will rise as patients become more aware of how effective these medications are at treating different heart ailments.

    Robust Adoption of the Product in Various Applications to Stimulate Market Growth

    Another important element projected to fuel the global market expansion is the effectiveness of these medications as anticoagulants. Indisputable elements like technological developments and the introduction of novel goods are also projected to significantly fuel the growth of the global market throughout the forecast period.

    The steady increase in the consumption of these medications has sped up efforts to create LMWH. Furthermore, other forms like Ultra-low Molecular Weight Heparin have emerged due to technical breakthroughs (ULMWH). As a result, these elements are anticipated to favorably affect the market over the forecast period.

    Restraints

    Lack of Raw Materials and Increased Prices Will Limit Market Growth

    The limited raw materials availability by the Chinese for producing products based on porcine is one of the major restraints on expanding the worldwide market. African Swine Fever (ASF), a lethal disease for swine, has recently caused numerous outbreaks in China, which has resulted in the widespread slaughter of pigs to manage outbreaks.

    As a result, these elements may contribute to the ongoing scarcity of raw materials needed to produce goods. The second factor limiting the market’s growth in the coming years is the higher prices involved with LMWH, which can prevent it from being more widely adopted in emerging markets.

    Trends

    Throughout the Forecast Period, Low Molecular Weight Heparin (Lmwh) is Anticipated to Hold a Sizable Market Share

    Throughout the forecast period, Low Molecular Weight Heparin (LMWH) is anticipated to hold a sizable market share. Low molecular weight heparin (LMWH), an anticoagulant, is injected subcutaneously or intravenously. Examples include enoxaparin and dalteparin, which function by triggering antithrombin III, which then renders factor Xa and thrombin inactive to induce their action.

    COVID-19 Impact Analysis

    Due to the Critical Significance of Such Products and Their Increased Inclusion in the Treatment of COVID-19 Protocols, the Market Has Shown Steady Growth

    The drug is regarded as a life-saving treatment for some chronic illnesses; hence the COVID-19 pandemic had a favorable impact on the market. Additionally, the use of this drug in COVID-19 therapy has expanded the market for certain treatment methods due to the buildup of specific product types.

    However, due to a steep decline in hospital visits globally and supply concerns about the raw material obtained from China, the pandemic, in some cases, generated some barriers to expanding the global market in the early days of the epidemic. The worldwide market, however, made a good recovery from the pandemic’s initial severe effects.

    Regional Analysis

    North America Was the Market Leader and Generated the Highest Revenue Share

    North America was the dominant region and generated the highest revenue share. The increase in cardiovascular diseases and accidents brings this on. Additionally, variables contributing to the region’s high percentage include rising healthcare spending and patient understanding in this area.

    Every year, one in four Americans in the US pass away from cardiovascular disease, making it one of the most common reasons of death in the nation.

    Asia Pacific is Expected to Have the Market’s Fastest Growth

    The market is anticipated to grow fastest in the Asia-Pacific heparin market over the anticipated period. Some of the main drivers of the expansion are the increasing geriatric population, the large population suffering from chronic diseases & developing economy.

    Additionally, Asia-Pacific is the region that supplies the most API and crude heparin. This benefits regional businesses like Pharmax Lifesciences. Generic versions of medications whose patents have expired are produced locally at a reasonable price.

    Global-Heparin-Market-regional-analysis

    Key Regions

    • North America
      • The US
      • Canada
      • Mexico
    • Western Europe
      • Germany
      • France
      • The UK
      • Spain
      • Italy
      • Portugal
      • Ireland
      • Austria
      • Switzerland
      • Benelux
      • Nordic
      • Rest of Western Europe
    • Eastern Europe
      • Russia
      • Poland
      • The Czech Republic
      • Greece
      • Rest of Eastern Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Australia & New Zealand
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
      • Rest of APAC
    • Latin America
      • Brazil
      • Colombia
      • Chile
      • Argentina
      • Costa Rica
      • Rest of Latin America
    • Middle East & Africa
      • Algeria
      • Egypt
      • Israel
      • Kuwait
      • Nigeria
      • Saudi Arabia
      • South Africa
      • Turkey
      • United Arab Emirates
      • Rest of MEA

    Key Players Analysis

    With the presence of many local and regional players, the market for Global Heparin Market is fragmented. Market players are subject to intense competition from top players, particularly those with strong brand recognition and high distribution networks. Companies have gained various expansion strategies, such as partnerships and product launches, to stay in the competition.

    Recent Development

    • In March 2022, To expand its distribution network, Hepalink Group announced that the APIs for heparin sodium & enoxaparin sodium had been approved in India.
    • In April 2021, Fresenius Kabi announced the availability of 2 new heparin sodium presentations in cozy, ready-to-use Freeflex IV bags inside the United States.
    • In February 2020, Meitheal Pharmaceuticals announced that the FDA had authorized plans for future facility growth and additional manufacturing capacity for producing Heparin Sodium Injection.

    Listed below are some of the most prominent bio-based surface disinfectant industry players.

    Market Key Players

    • GlaxoSmithKline plc
    • Aspen Pharmacare Holdings Limited
    • Braun Medical Inc.
    • Baxter International Inc.
    • Cipla Ltd.
    • Reddy’s Laboratories Ltd.
    • Hoffmann-La Roche Ltd.
    • Fresenius SE & Co. KGaA
    • Leo Pharma A/S
    • Novartis AG
    • Pfizer Inc.
    • OPOCRIN SPA.
    • Reddy’s Laboratories Ltd.
    • SARIA International GmbH
    • Sanofi
    • Teva Pharmaceutical Industries Ltd.
    • United Biotech (P) Ltd.
    • Viatris Inc.
    • Bio-pharma Co., ltd.
    • Other Key Players.

    Report Scope

    Report FeaturesDescription
    Market Value (2022)US$ 8.3 Bn
    Forecast Revenue (2032)US$ 13.0 Bn
    CAGR (2023-2032)4.7%
    Base Year for Estimation2022
    Historic Period2016-2022
    Forecast Period2023-2032
    Report CoverageRevenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments
    Segments CoveredBy Product (Weight Heparin, Unfractionated Heparin, Ultra-Low Molecular, and Low Molecular Weight Heparin), Application (Coronary Artery Disease, Atrial Fibrillation, Venous Thromboembolism, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Drug Stores & Retail Pharmacies)
    Regional AnalysisNorth America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; the Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA
    Competitive LandscapeGlaxoSmithKline plc, Aspen Pharmacare Holdings Limited, B. Braun Medical Inc., B. Braun Medical Inc., Baxter International Inc., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Fresenius Kabi, Fresenius SE & Co. KGaA, Leo Pharma A/S, Novartis AG., OPOCRIN S.P.A., Pfizer Inc., Reddy’s Laboratories Ltd., SARIA International GmbH, Sanofi, Teva Pharmaceutical Industries Ltd., United Biotech (P) Ltd., Viatris Inc., Bio-pharma Co., ltd., and Other Key Players.
    Customization ScopeCustomization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase OptionsWe have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)

    Frequently Asked Questions (FAQ)

    What is the current market size for the Heparin Market?

    According to a report by Market.us, the Heparin Market was valued at USD 8.3 billion in 2022 and is expected to reach USD 13.0 Million by 2032, growing at a CAGR of 18.60% during the forecast period.

    What are the key segments of the Heparin Market?

    The Heparin Market can be segmented based on By Product (Weight Heparin, Unfractionated Heparin, Ultra-Low Molecular, Low Molecular Weight Heparin), By Application (Coronary Artery Disease, Atrial Fibrillation, Venous Thromboembolism, Others), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Drug Stores & Retail Pharmacies).

    Who are the key players in the Heparin Market?

    Some of the key players in the Heparin Market include GlaxoSmithKline plc, Aspen Pharmacare Holdings Limited, Braun Medical Inc., Baxter International Inc., Cipla Ltd., Reddy's Laboratories Ltd., Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Leo Pharma A/S, Novartis AG, Pfizer Inc., OPOCRIN SPA., Reddy's Laboratories Ltd., SARIA International GmbH, Sanofi, Teva Pharmaceutical Industries Ltd., United Biotech (P) Ltd., Viatris Inc., Bio-pharma Co., ltd., Other Key Players.

    Heparin Market
    Heparin Market
    Published date: March 2023
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • GlaxoSmithKline plc
    • Aspen Pharmacare Holdings Limited
    • Braun Medical Inc.
    • Baxter International Inc.
    • Cipla Limited Company Profile
    • Reddy's Laboratories Ltd.
    • Hoffmann-La Roche Ltd.
    • Fresenius SE & Co. KGaA
    • Leo Pharma A/S
    • Novartis AG Company Profile
    • Pfizer Inc Company Profile
    • OPOCRIN SPA.
    • SARIA International GmbH
    • Sanofi Company Profile
    • Teva Pharmaceutical Industries Ltd. Company Profile
    • United Biotech (P) Ltd.
    • Viatris Inc.
    • Bio-pharma Co., ltd.
    • Other Key Players.
  • settingsSettings

Related Reports

  • Pet Pain Management Drugs Market
  • Loratadine Market
  • Location Based Advertising (LBA) Market
  • Methyl Methacrylate Market
  • Global Hem Flange Bonding Adhesives Market
  • Dry Construction System Market

Our Clients

  • Our Clients
Inquiry Before Buying

Heparin Market
  • 15768
  • March 2023
    • ★★★★★
      ★★★★★
    • (28)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
Multi User
$7,999
$3,499
USD / per unit
save 55%
Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library
Secured Payment Options
Secured Payment Options

© 2023 Market.Us. All Rights Reserved.